Related Experiment Video

Updated: Aug 18, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

[Role of LDL in cardiovascular diseases. New data and new recommendations]

E Bruckert1

  • 1Unité d'exploration métabolique pour la prévention des maladies cardiovasculaires, Hôpital Pitié-Salpêtrière, Paris (75), France.

Presse Medicale (Paris, France : 1983)
|March 31, 2005
PubMed

Insights

Aggressively lowering LDL-cholesterol with statins and new therapies reduces cardiovascular risk. Therapeutic education and new HDL treatments are key for clinical practice success and patient compliance.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Context:

  • Hypercholesterolemia management has evolved significantly, driven by large-scale clinical trials.
  • Statins have proven effective in reducing cardiovascular morbidity and mortality by targeting LDL-cholesterol.
  • Recent research supports an aggressive cholesterol-lowering strategy, even in patients with lower baseline levels.

Purpose:

  • To review the progress in hypercholesterolemia management, focusing on LDL-cholesterol reduction strategies.
  • To discuss the challenges in translating aggressive lipid-lowering strategies into clinical practice.
  • To highlight the role of therapeutic education and emerging HDL-focused treatments.

Summary:

  • Extensive clinical trials demonstrate statin efficacy in lowering LDL-cholesterol, reducing cardiovascular events and mortality.
  • Newer, potent statins and combination therapies enhance the ability to achieve very low cholesterol levels.
  • Clinical implementation faces barriers including patient/practitioner hesitancy, compliance issues, and cost concerns.

Impact:

  • Aggressive LDL-cholesterol reduction strategies, supported by advanced therapies, offer improved cardiovascular prevention.
  • Therapeutic education is crucial for enhancing patient compliance with lipid-lowering treatments.
  • Future advancements in HDL-targeting therapies may further enhance cardiovascular disease prevention.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...